Akira Shimamoto
Overview
Explore the profile of Akira Shimamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shimamoto A, Kojo N, Saiki H, Hayashi A, Takao M
Respirol Case Rep
. 2025 Feb;
13(2):e70127.
PMID: 39980580
Pulmonary enteric adenocarcinoma (PEAC) is an extremely rare subtype of non-small cell lung cancer, characterised by histopathological features that resemble colorectal adenocarcinoma. Here, we report a case of PEAC in...
2.
Yamamoto Y, Takahashi R, Kinehara M, Yano K, Kuramoto T, Shimamoto A, et al.
Genes (Basel)
. 2024 May;
15(5).
PMID: 38790171
Cellular senescence is an irreversible growth arrest that acts as a barrier to cancer initiation and progression. Histone alteration is one of the major events during replicative senescence. However, little...
3.
Funatsuki T, Ogata H, Tahara H, Shimamoto A, Takekita Y, Koshikawa Y, et al.
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569574
Individual treatment outcomes to antidepressants varies widely, yet the determinants to this difference remain elusive. MicroRNA (miRNA) gene expression regulation in major depressive disorder (MDD) has attracted interest as a...
4.
Ogata H, Higasa K, Kageyama Y, Tahara H, Shimamoto A, Takekita Y, et al.
J Affect Disord
. 2023 Jul;
339:538-546.
PMID: 37467797
Background: MicroRNAs (miRNAs) and circulating cell-free mitochondrial DNA (ccf-mtDNA) have attracted interest as biological markers of affective disorders. In response to stress, it is known that miRNAs in mitochondria diffuse...
5.
Asanuma K, Tsujii M, Hagi T, Nakamura T, Kita K, Shimamoto A, et al.
Front Oncol
. 2023 May;
13:1104536.
PMID: 37152065
Background: Chest wall malignant tumor (including primary and metastatic lesions) is rare, representing less than 5% of all thoracic malignancies. Local control of chest wall malignancies requires wide resection with...
6.
Tsuge K, Shimamoto A
Genes (Basel)
. 2022 Oct;
13(10).
PMID: 36292687
A rare and autosomal recessive premature aging disorder, Werner syndrome (WS) is characterized by the early onset of aging-associated diseases, including shortening stature, alopecia, bilateral cataracts, skin ulcers, diabetes, osteoporosis,...
7.
Toyomasu Y, Matsui K, Omori K, Takada A, Imanaka-Yoshida K, Tawara I, et al.
Thorac Cancer
. 2022 Sep;
13(20):2904-2907.
PMID: 36047568
Radiation-induced lung damage (RILD) is a critical problem in lung cancer radiotherapy, and it is difficult to predict its severity. Although no biomarkers for RILD have been established, tenascin C...
8.
Kawaguchi K, Ito A, Kaneda S, Kawaguchi T, Shimamoto A, Takao M
Asian J Endosc Surg
. 2022 Jul;
16(1):147-151.
PMID: 35781102
Introduction: Due to its many technical advantages, the scope of robot-assisted thoracic surgery (RATS) is expanding to include extended pulmonary resection. Among such procedures, right bilobectomy is one with a...
9.
Kato M, Ogata H, Tahara H, Shimamoto A, Takekita Y, Koshikawa Y, et al.
Int J Mol Sci
. 2022 Apr;
23(7).
PMID: 35409234
Major depressive disorder (MDD) is a life-impairing disorder, and early successful treatment is important for a favorable prognosis. However, early response to antidepressants differs widely among individuals, and is difficult...
10.
Ito A, Kaneda S, Shimamoto A, Takao M
Mediastinum
. 2022 Feb;
3:26.
PMID: 35118254
Thoracoscopic subxiphoid approaches, such as the single-port thymectomy (SPT) and dual-port thymectomy (DPT) approaches have been demonstrated to have several advantages compared with the traditional median sternotomy approach or the...